Healthtech Startups
17,197 companies tagged Healthtech, with their investors and founders.
0 investors
0 investors
DEPTH Health provides AI-driven patient flow orchestration and routing software for health systems, using simulation and real-time clinical decision support to optimize hospital operations and patient movement. The platform combines retrospective analysis with real-time recommendations to improve clinical efficiency and reduce operational bottlenecks in healthcare settings.
0 investors
DepYmed is a biotech company developing orally bioavailable small-molecule inhibitors of the enzyme PTP1B and copper-chelating compounds as therapeutics for cancer, rare diseases, and conditions such as Rett Syndrome and Wilson Disease. Its pipeline targets protein tyrosine phosphatase signaling pathways implicated in metabolic, inflammatory, and neurodegenerative diseases.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Develo builds pediatric practice management software that goes beyond a traditional EMR, handling scheduling, clinical charting, billing, and family engagement for independent pediatric practices. Its FHIR-native platform uses a family-centered data architecture to support adolescent confidentiality and integrations with text, e-fax, e-prescribe, e-lab, payer, and vaccine registry systems.
0 investors
0 investors
0 investors
0 investors
0 investors
Diabetes Reversal Group (DRG) offers a patented, non-drug program for people with Type 2 Diabetes that combines dietary guidance, nutritional supplements, and exercise to reduce or eliminate reliance on glucose-lowering medications under medical supervision. The program is delivered through affiliated clinics to diabetic patients internationally.
0 investors
0 investors
0 investors
0 investors
Dialectic Therapeutics is a clinical-stage biotechnology company developing anti-cancer drugs using its Antiapoptotic Protein Targeted Degradation (APTaD) platform, which induces cancer cells to degrade proteins such as BCL-XL. Its lead candidate, DT2216, is in Phase 1/2 trials for fibrolamellar carcinoma and platinum-resistant ovarian cancer.
0 investors
Diality is a medical device company developing a home hemodialysis machine and related solutions for patients with kidney disease, aimed at supporting new decentralized kidney-care models. The Series-B company serves the dialysis and nephrology market and is based in Irvine, California.
0 investors
0 investors